New Born Eye Imaging Systems Market is Likely to Witness Steady Growth by 2032

The global New Born Eye Imaging Systems market revenue is estimated to be valued US$ 374.3 million by 2032, up from US$ 202.7 million in 2022, growing at a 5.7% CAGR during the forecast period.

The eye imaging system is a device that aids in the detection of eye-related problems.

The need for New Born Eye Imaging Systems is growing as the number of people suffering from various eye disorders rises. Newborn babies are also vulnerable to vision problems such as retinopathy of prematurity (ROP), which can cause vision loss and damage to blood cells.

As a result, New Born Eye Imaging Systems are predicted to grow significantly during the forecast period.

New Born Eye Imaging Systems: Drivers and Restraints

New born eye imaging is a growing market, with many players developing innovative imaging devices and raising funds for research on New Born Eye Imaging Systems. For example, in May 2017, Visunex Medical Systems, Inc. raised USD$ 20 million for research, development, and manufacturing of New Born Eye Imaging Systems.

New Born Eye Imaging Systems: Overview

In March 2012, Russia's third president approved the purchase of a new born eye imaging system from Clarity Medical Systems, Inc., and launched the RetCam digital imaging programme in the Russian Federation for the treatment of prematurely born infants.

New Born Eye Imaging Systems: Key Players

Some players in New Born Eye Imaging Systems Market include Visunex Medical Systems, Inc., Eye Photo Systems, Merge Healthcare Incorporated, D-EYE S.r.l., Imagine Eyes, Natus Medical Incorporated and Servicom Medical (Singapore) Pte Ltd.

Browse More@ https://www.futuremarketinsights.com/reports/new-born-eye-imaging-systems-market

Key Segments in the New Born Eye Imaging Systems Market

By Disease Type:

  • Retinopathy of prematurity
  • Ocular development
  • Refractive state
  • Strabismus
  • Visual functions
  • Visual acuity
  • Visual fields
  • Colour vision

By Device Type:

  • Basic Device
  • Wireless Device

By End-User:

  • Hospital
  • Ophthalmology Diagnosis Centre
  • Ambulatory Surgical Centre
  • Other

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasound Scanners in emergency medical service
Read more

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

Antidiabetics Market to reach US$ 223 billion by 2032, growing at a 9.6% CAGR from 2022 to 2032 | Future Market Insights, Inc.

Image
The global Antidiabetics Market is expected to earn US$ 223 billion while expanding at a CAGR of 9.6% during the forecast period. The rising prevalence of diabetes worldwide can be attributed to the market's expansion. The ageing baby boomer population is another factor driving the market during the forecast period. According to the International Diabetes Federation, the global diabetes incidence will increase from 366 million in 2011 to 552 million by 2030. During the forecast period, the industry is expected to benefit from a significant increase in the number of diabetic patients. Furthermore, new product development is expected to benefit the market in the near future. For example, Novo Nordisk, a Danish pharmaceutical company, announced the launch of oral semaglutide for the treatment of Type 2 diabetes in India in January 2022. Furthermore, the development of advanced pumps based on smart technologies like AI and ML is expected to open up a slew of new doors. For exampl
Read more